Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Kazutsune, Harada"'
Autor:
Tomoaki Morioka, Yasuo Imanishi, Daichi Miyaoka, Atsuto Inoue, Noriyuki Hayashi, Masaaki Inaba, Masanori Emoto, Katsuhito Mori, Ikue Kobayashi, Tomoe Hirakawa, Tomomi Tateishi, Yuki Nagata, Kazutsune Harada
Publikováno v:
Journal of Bone and Mineral Metabolism. 39:430-438
Etelcalcetide binds to the extracellular domain of the calcium-sensing receptor (CaSR), while cinacalcet binds to the 7-transmembrane domain of the CaSR; however, it is unknown, whether etelcalcetide has similar effects to cinacalcet on parathyroid h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e152efe3d07b93de065fe645630c5e45
https://doi.org/10.1007/s00774-020-01169-z
https://doi.org/10.1007/s00774-020-01169-z
Autor:
Hiroyuki Yamada, Masaaki Inaba, Yoshihiro Sugiura, Kazutsune Harada, Atsuto Inoue, Masanori Emoto, Tomoe Hirakawa, Mikiyasu Taguchi, Ikue Kobayashi, Noriyuki Hayashi, Yasuo Imanishi, Daichi Miyaoka, Aiko Fujioka
Publikováno v:
Journal of Bone and Mineral Metabolism. 39:396-403
Etelcalcetide (Parsabiv®, AMG 416/ONO-5163) is a novel allosteric modulator for the calcium-sensing receptor approved for hemodialysis patients with secondary hyperparathyroidism of uremia. Etelcalcetide reduced parathyroid hormone levels in hemodia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cdf37fc17e8b599df06d1a13824c6b3
https://doi.org/10.1007/s00774-020-01158-2
https://doi.org/10.1007/s00774-020-01158-2
Autor:
Tsukasa Okiyoneda, Kazutsune Harada, Kaori Yamahira, Ikuo Wada, Yasuaki Hashimoto, Keiko Ueno, Mary Ann Suico, Tsuyoshi Shuto, Hirofumi Kai
Publikováno v:
Journal of Pharmacological Sciences, Vol 95, Iss 4, Pp 471-475 (2004)
To examine the unknown trafficking pathway of the cystic fibrosis transmembrane conductance regulator (CFTR) from the endoplasmic reticulum (ER), we utilized baby hamster kidney cells stably expressing CFTR fused with green fluorescent protein. CFTR
Externí odkaz:
https://doaj.org/article/211c0fc9e7194ed6b2ee3afc1825e529
Autor:
Kazutsune Harada, Yasushi Hirota, Aiko Fujioka, Hiroyuki Yamada, Masakazu Konno, Atsuto Inoue
Publikováno v:
European Journal of Pharmacology. 842:139-145
Etelcalcetide hydrochloride (Parsabiv®, ONO-5163/AMG 416) is an allosteric modulator of the calcium (Ca)-sensing receptor that was originally produced by KAI Pharmaceuticals Inc. (now Amgen Inc.). It has recently been approved as the first intraveno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46cdac8aaf455c50f26834ba7294a8db
https://doi.org/10.1016/j.ejphar.2018.10.021
https://doi.org/10.1016/j.ejphar.2018.10.021
Publikováno v:
Folia Pharmacologica Japonica. 150:98-113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a77278dfb4d8821b59379e3caa0ed247
https://doi.org/10.1254/fpj.150.98
https://doi.org/10.1254/fpj.150.98
Autor:
Atsuto Inoue, Yasuo Imanishi, Daichi Miyaoka, Mikiyasu Taguchi, Hiroyuki Yamada, Sugiura Yoshihiro, Kazutsune Harada, Aiko Fujioka, Noriyuki Hayashi
Publikováno v:
Nephrology Dialysis Transplantation. 34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b5320b11911192e32a4828ab98c12d9
https://doi.org/10.1093/ndt/gfz106.fp031
https://doi.org/10.1093/ndt/gfz106.fp031
Autor:
Kazutsune, Harada, Aiko, Fujioka, Masakazu, Konno, Atsuto, Inoue, Hiroyuki, Yamada, Yasushi, Hirota
Publikováno v:
European journal of pharmacology. 842
Etelcalcetide hydrochloride (Parsabiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::81814dafe436201e68860780f4698d78
https://pubmed.ncbi.nlm.nih.gov/30342948
https://pubmed.ncbi.nlm.nih.gov/30342948
Publikováno v:
Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 150(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::444df19ff4bbd699459a4ebd7aaf3d4d
https://pubmed.ncbi.nlm.nih.gov/28794306
https://pubmed.ncbi.nlm.nih.gov/28794306
Autor:
Atsuto, Inoue, Kazutsune, Harada
Publikováno v:
Clinical calcium. 27(4)
Etelcalcetide hydrochloride is the first intravenous calcimimetics agent for secondary hyperparathyroidism (SHPT). Etelcalcetide hydrochloride is to be administered through dialysis circuit by physician or medical staff upon completion of dialysis an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::15db0dc8a76d99413f7c80a9ee1a09d7
https://pubmed.ncbi.nlm.nih.gov/28336830
https://pubmed.ncbi.nlm.nih.gov/28336830
Autor:
Akiko Niibori, Tsukasa Okiyoneda, Masahito Ikawa, Kazutsune Harada, Marek Duszyk, Mary Ann Suico, Marek Michalak, Tsuyoshi Shuto, Taijun Kohno, Hirofumi Kai, Ikuo Wada
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1783:1585-1594
Cystic fibrosis (CF) is caused by the mutation in CF transmembrane conductance regulator (CFTR), a cAMP-dependent Cl(-) channel at the plasma membrane of epithelium. The most common mutant, DeltaF508 CFTR, has competent Cl(-) channel function, but fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba5bff9dcb91e54967cc29d38162022f
https://doi.org/10.1016/j.bbamcr.2008.04.002
https://doi.org/10.1016/j.bbamcr.2008.04.002